August 2023

Syngene International Ltd is an integrated research, development and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. Syngene’s 4500+ scientists offer both skills and the capacity to deliver great science, robust data management and IP security and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

Post : Officer to Sr.Executive

Macleods Pharmaceuticals, fastest growing company was established in 1986. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140 plus countries. Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities.

Amgen is one of the world’s leading independent biotechnology companies. For over 4 decades, Amgen has pioneered biotechnology breakthroughs, to bring state-of-the-art medicines from laboratory to the patient. Amgen has not only discovered and developed innovative human therapeutics, but has invested in cutting edge manufacturing capability and support services to deliver these exciting therapies to medical teams around the world. Japan and Asia Pacific (JAPAC) is the fastest growing region in Amgen.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happinessand hope.

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Post : Regulatory Manager - CHC

By the letter number Araj / UTB / 2023/369 dated 24.7.2023 of the Director (Non-Gazetted) Medical and Health Services, Rajasthan Jaipur, the nursing cadre and the letter number Araj / UTB / 2023/392 dated 04.8.2023 filled the vacant posts of Paramedical and Pharmacist cadre. Order of even number of the department on necessary temporary basis p. 1 (1) Chiswa / 2 / 2014 dated 04.10.2014 in Palna dated 04.10.2014 for the following posts from 10.00 AM to 14.08.2023 to 6.00 PM Interested candidates can apply through Google link .

Maharashtra Government Rural Development Department Government Decision No. Miscellaneous-2022/P.No.11/Aastha-8 Dated 15 November 2022, Government of Maharashtra General Administration Department Government Decision No. 1222/P.No. 136/Ka-13B dated 21 November 2022, Government of Maharashtra, General Administration Department Government Decision no. BCC 2018/Pro.No.427/16-B, dt. 10th May, 2023, Government of Maharashtra, Rural Development Department Government Circular No.- Miscellaneous 2022/P.No.11/Aastha-8, dt.

IISERs were created through a proclamation of Ministry of Education, Government of India, to promote quality education and research in science and related areas. The first two IISERs (Pune and Kolkata) were established in 2006. This was followed by an Institute at Mohali (2007), Bhopal & Trivandrum (2008), Tirupati (2015), and Berhampur (2016). IISERs were incorporated as Institutions of National Importance under the umbrella of the NIT (Amendment) Act, 2012 (NIT Act 2007). The Act was further amended in 2014, entitled the NITSER ACT 2014.